1. Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003; 21:4336–4341.
2. Sato Y, Motoyama S, Maruyama K, et al. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement. J Am Coll Surg. 2005; 201:188–193.
3. Kennedy WR, Amdur RJ, Boyce BJ, et al. Neck management with total laryngectomy and adjuvant radiotherapy in locally advanced larynx cancer. Oncol Res Treat. 2017; 40:503–506.
4. Muto M, Nakane M, Katada C, et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer. 2004; 101:1375–1381.
5. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953; 6:963–968.
6. Bova R, Goh R, Poulson M, et al. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope. 2005; 115:864–869.
7. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001; 49:907–916.
8. Muto M, Minashi K, Yano T, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010; 28:1566–1572.
9. Muto M, Satake H, Yano T, et al. Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer. Gastrointest Endosc. 2011; 74:477–484.
10. Hanaoka N, Ishihara R, Takeuchi Y, et al. Endoscopic submucosal dissection as minimally invasive treatment for superficial pharyngeal cancer: a phase II study (with video). Gastrointest Endosc. 2015; 82:1002–1008.
11. Katada C, Muto M, Fujii S, et al. Transoral surgery for superficial head and neck cancer: National Multi-Center Survey in Japan. Cancer Med. 2021; 10:3848–3861.
12. Shimizu Y, Omori T, Yokoyama A, et al. Endoscopic diagnosis of early squamous neoplasia of the esophagus with iodine staining: high-grade intra-epithelial neoplasia turns pink within a few minutes. J Gastroenterol Hepatol. 2008; 23:546–550.
13. Ishihara R, Kanzaki H, Iishi H, et al. Pink-color sign in esophageal squamous neoplasia, and speculation regarding the underlying mechanism. World J Gastroenterol. 2013; 19:4300–4308.
14. Inoue H, Endo M, Takeshita K, et al. A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc. 1992; 6:264–265.
15. The Japan Society for Head and Neck Cancer. General rules for clinical studies on head and neck cancer. The 6th ed, revised version. Kanehara & Co., Ltd;2019. Japanese.
16. Wahlberg PC, Andersson KE, Biörklund AT, et al. Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period. Head Neck. 1998; 20:714–719.
17. Kinjo Y, Nonaka S, Oda I, et al. The short-term and long-term outcomes of the endoscopic resection for the superficial pharyngeal squamous cell carcinoma. Endosc Int Open. 2015; 3:E266–E273.
18. Yamaguchi H, Sato H, Tsukahara K, et al. Co-treatment with endoscopic laryngopharyngeal surgery and endoscopic submucosal dissection. Auris Nasus Larynx. 2021; 48:457–463.
19. Morimoto H, Yano T, Yoda Y, et al. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma. World J Gastroenterol. 2017; 23:1051–1058.
20. Yamasaki Y, Ishihara R, Hanaoka N, et al. Pethidine hydrochloride is a better sedation method for pharyngeal observation by transoral endoscopy compared with no sedation and midazolam. Dig Endosc. 2017; 29:39–48.